Literature DB >> 9806905

Isolation and characterization of the rat huntingtin promoter.

C Holzmann1, W Mäueler, D Petersohn, T Schmidt, G Thiel, J T Epplen, O Riess.   

Abstract

Huntington's disease (HD) is a neurodegenerative disorder caused by a (CAG)>37 repeat expansion in a novel gene of unknown function. Although the huntingtin gene is expressed in neuronal and non-neuronal tissues, the disease affects nerve cells of selected regional areas of the central nervous system. To gain insight into the regulation of the HD gene we analysed 1348 bp of the rat huntingtin promoter region. This region lacks a TATA and a CAAT box, is rich in GC content and has several consensus sequences for binding sites for SP1, PEA3, Sif and H2A. The stretch between nucleotides -56 and -206 relative to the first ATG is highly conserved between human and rodents and it harbours several potential binding sites for transcription factors. We analysed deletion mutants fused with the chloramphenicol acetyltransferase reporter gene in transfected, HD-expressing neuronal (NS20Y, NG108-15) and non-neuronal Chinese hamster ovary cell lines. Hence these cells should contain the required trans-acting factors necessary for HD gene expression. Partial deletion of the evolutionarily conserved part of the promoter significantly decreases the activity in both neuronal and non-neuronal cells, indicating that the core promoter activity is located between nucleotides -332 and -15. DNase I footprinting and electrophoretic mobility-shift assays were used to define the nucleotide positions and binding affinity of DNA-protein interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806905      PMCID: PMC1219862          DOI: 10.1042/bj3360227

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  44 in total

1.  DNA-binding properties of the product of the testis-determining gene and a related protein.

Authors:  N Nasrin; C Buggs; X F Kong; J Carnazza; M Goebl; M Alexander-Bridges
Journal:  Nature       Date:  1991-11-28       Impact factor: 49.962

2.  Characterization of the rat spinocerebellar ataxia type 3 gene.

Authors:  I Schmitt; T Brattig; M Gossen; O Riess
Journal:  Neurogenetics       Date:  1997-09       Impact factor: 2.660

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Functional analysis of the Huntington's disease (HD) gene promoter.

Authors:  R Coles; R Caswell; D C Rubinsztein
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

5.  Regulation of synapsin I gene expression by the zinc finger transcription factor zif268/egr-1.

Authors:  G Thiel; S Schoch; D Petersohn
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

6.  Different binding specificities and transactivation of variant CRE's by CREB complexes.

Authors:  D M Benbrook; N C Jones
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

7.  Huntington's disease gene (IT15) is widely expressed in human and rat tissues.

Authors:  S H Li; G Schilling; W S Young; X J Li; R L Margolis; O C Stine; M V Wagster; M H Abbott; M L Franz; N G Ranen
Journal:  Neuron       Date:  1993-11       Impact factor: 17.173

8.  Isolation and characterization of target sequences of the chicken CdxA homeobox gene.

Authors:  Y Margalit; S Yarus; E Shapira; Y Gruenbaum; A Fainsod
Journal:  Nucleic Acids Res       Date:  1993-10-25       Impact factor: 16.971

9.  Differential regulation of chromogranin B and synapsin I gene promoter activity by cAMP and cAMP-dependent protein kinase.

Authors:  S Jüngling; G Cibelli; M Czardybon; H H Gerdes; G Thiel
Journal:  Eur J Biochem       Date:  1994-12-15

10.  Sex-reversing mutations affect the architecture of SRY-DNA complexes.

Authors:  A Pontiggia; R Rimini; V R Harley; P N Goodfellow; R Lovell-Badge; M E Bianchi
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

View more
  6 in total

1.  An upstream open reading frame impedes translation of the huntingtin gene.

Authors:  Joseph Lee; Eun Hee Park; Graeme Couture; Isabelle Harvey; Philippe Garneau; Jerry Pelletier
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

2.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

3.  A SNP in the HTT promoter alters NF-κB binding and is a bidirectional genetic modifier of Huntington disease.

Authors:  Kristina Bečanović; Anne Nørremølle; Scott J Neal; Chris Kay; Jennifer A Collins; David Arenillas; Tobias Lilja; Giulia Gaudenzi; Shiana Manoharan; Crystal N Doty; Jessalyn Beck; Nayana Lahiri; Elodie Portales-Casamar; Simon C Warby; Colúm Connolly; Rebecca A G De Souza; Sarah J Tabrizi; Ola Hermanson; Douglas R Langbehn; Michael R Hayden; Wyeth W Wasserman; Blair R Leavitt
Journal:  Nat Neurosci       Date:  2015-05-04       Impact factor: 24.884

4.  Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine.

Authors:  S Iuchi; G Hoffner; P Verbeke; P Djian; H Green
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

5.  Impaired Decision Making and Loss of Inhibitory-Control in a Rat Model of Huntington Disease.

Authors:  Nicole El Massioui; Charlotte Lamirault; Sara Yagüe; Najia Adjeroud; Daniel Garces; Alexis Maillard; Lucille Tallot; Libo Yu-Taeger; Olaf Riess; Philippe Allain; Huu Phuc Nguyen; Stephan von Hörsten; Valérie Doyère
Journal:  Front Behav Neurosci       Date:  2016-10-26       Impact factor: 3.558

Review 6.  Transcriptional Regulation of the Huntingtin Gene.

Authors:  Sarah B Thomson; Blair R Leavitt
Journal:  J Huntingtons Dis       Date:  2018
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.